{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:23:02Z","timestamp":1761844982983},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lipidjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jacl.2019.03.002","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T07:28:38Z","timestamp":1552894118000},"page":"432-442","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Guidelines impact cholesterol management"],"prefix":"10.1016","volume":"13","author":[{"given":"Stephanie","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiumars","family":"Zolfaghari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen L.","family":"Rascati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurel A.","family":"Copeland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Godley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"McNeal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"25 Part B","key":"10.1016\/j.jacl.2019.03.002_bib1","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jacl.2019.03.002_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacl.2015.08.002","article-title":"National lipid association annual summary of clinical lipidology 2016","volume":"10","author":"Bays","year":"2016","journal-title":"J Clin Lipidol"},{"issue":"3","key":"10.1016\/j.jacl.2019.03.002_bib3","doi-asserted-by":"crossref","first-page":"e004909","DOI":"10.1161\/JAHA.116.004909","article-title":"Effect of 2013 ACC\/AHA blood cholesterol guidelines on statin treatment patterns and low-density lipoprotein cholesterol in atherosclerotic cardiovascular disease patients","volume":"6","author":"Okerson","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"Suppl 2","key":"10.1016\/j.jacl.2019.03.002_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP171764.APPGL","article-title":"American association of clinical endocrinologists and American college of endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease","volume":"23","author":"Jellinger","year":"2017","journal-title":"Endocr Pract"},{"issue":"Supplement 1","key":"10.1016\/j.jacl.2019.03.002_bib5","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.2337\/dc17-S012","article-title":"9. Cardiovascular disease and risk management","volume":"40","author":"Association","year":"2017","journal-title":"Diabetes Care"},{"issue":"25","key":"10.1016\/j.jacl.2019.03.002_bib6","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2019.03.002_bib7","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1161\/CIRCULATIONAHA.117.029381","article-title":"High quality statin trials support the 2013 ACC\/AHA cholesterol guidelines after HOPE-3: the multi-ethnic study of atherosclerosis","volume":"136","author":"Mortensen","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2019.03.002_bib8","unstructured":"Major dyslipidemia guidelines and their discrepancies: a need for consensus. American College of Cardiology. Available at: https:\/\/www.acc.org\/latest-in-cardiology\/articles\/2018\/04\/24\/08\/56\/major-dyslipidemia-guidelines-and-their-discrepancies. Accessed July 4, 2018."},{"issue":"9","key":"10.1016\/j.jacl.2019.03.002_bib9","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.mayocp.2014.06.016","article-title":"A summary and critical assessment of the 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: filling the gaps","volume":"89","author":"Lopez-Jimenez","year":"2014","journal-title":"Mayo Clin Proc"},{"issue":"15","key":"10.1016\/j.jacl.2019.03.002_bib10","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/eurheartj\/ehu107","article-title":"The ACC\/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC\/EAS guidelines for the management of dyslipidaemias 2011","volume":"35","author":"Ray","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2019.03.002_bib11","first-page":"18","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"25708","author":"Grundy Scott","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.jacl.2019.03.002_bib12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/JAHA.116.005205","article-title":"Initiation patterns of statins in the 2 years after release of the 2013 American College of Cardiology\/American Heart Association (ACC\/AHA) cholesterol management guideline in a large US health plan","volume":"6","author":"Olufade","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.jacl.2019.03.002_bib13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/jamacardio.2016.5922","article-title":"Adoption of the 2013 American College of Cardiology\/American Heart Association cholesterol management guideline in cardiology practices nationwide","volume":"2","author":"Pokharel","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"2","key":"10.1016\/j.jacl.2019.03.002_bib14","first-page":"160","article-title":"Non-HDL cholesterol as a metric of good quality of care","volume":"38","author":"Virani","year":"2011","journal-title":"Tex Heart Inst J"},{"issue":"5","key":"10.1016\/j.jacl.2019.03.002_bib16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"6","key":"10.1016\/j.jacl.2019.03.002_bib17","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"10.1016\/j.jacl.2019.03.002_bib18","doi-asserted-by":"crossref","first-page":"652","DOI":"10.18553\/jmcp.2007.13.8.652","article-title":"LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO","volume":"13","author":"Nag","year":"2007","journal-title":"J Manag Care Pharm"},{"issue":"1","key":"10.1016\/j.jacl.2019.03.002_bib19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0002-9149(97)00298-1","article-title":"The rule of 5 and the rule of 7 in lipid-lowering by statin drugs","volume":"80","author":"Roberts","year":"1997","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.jacl.2019.03.002_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/107424849700200102","article-title":"Cerivastatin, a new potent synthetic HMG Co-a reductase inhibitor: effect of 0.2 mg daily in subjects with primary hypercholesterolemia","volume":"2","author":"Stein","year":"1997","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.jacl.2019.03.002_bib21","first-page":"901","article-title":"Impact of the 2013 cholesterol guideline on patterns of lipid-lowering treatment in patients with atherosclerotic cardiovascular disease or diabetes after 1 year","volume":"22","author":"Tran","year":"2016","journal-title":"J Manag Care Spec Pharm"},{"issue":"1","key":"10.1016\/j.jacl.2019.03.002_bib22","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jacc.2016.03.519","volume":"68","author":"Lloyd-Jones","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"0","key":"10.1016\/j.jacl.2019.03.002_bib23","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/j.jacl.2015.06.014","article-title":"Temporal trends in lipid screening and therapy among youth from 2002\u20132012","volume":"9","author":"Zachariah","year":"2015","journal-title":"J Clin Lipidol"},{"issue":"12","key":"10.1016\/j.jacl.2019.03.002_bib24","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1258\/jrsm.2011.110180","article-title":"The answer is 17 years, what is the question: understanding time lags in translational research","volume":"104","author":"Morris","year":"2011","journal-title":"J R Soc Med"},{"issue":"8","key":"10.1016\/j.jacl.2019.03.002_bib25","doi-asserted-by":"crossref","first-page":"914.e5","DOI":"10.1016\/j.amjmed.2015.02.013","article-title":"The new lipid guidelines: what do primary care clinicians think?","volume":"128","author":"Jam\u00e9","year":"2015","journal-title":"Am J Med"},{"issue":"6 Suppl","key":"10.1016\/j.jacl.2019.03.002_bib26","doi-asserted-by":"crossref","first-page":"1A","DOI":"10.1016\/j.amjcard.2016.05.025","article-title":"Introduction: what have we learned since the 2013 ACC\/AHA guidelines?","volume":"118","author":"Blumenthal","year":"2016","journal-title":"Am J Cardiol"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287419300443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287419300443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T22:39:23Z","timestamp":1663108763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287419300443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1933287419300443"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2019.03.002","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guidelines impact cholesterol management","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2019.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 National Lipid Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}